NEW YORK, Dec. 1, 2014—Kantar Health, a leading global healthcare consulting firm, will host a webinar, “Patient Affordability: The Ongoing Crisis and Opportunities for Pharma,” at 12pm ET on Thursday, Dec. 4.
Patient affordability is one of the leading non-clinical attributes in an oncologist’s choice of one therapeutic agent over another. Affordability will continue to grow in importance as insurance benefit designs shift greater cost burden onto the patient. Financial assistance programs are evolving, and oncology practices place increasing value on them. Minimizing practice burden should be a key consideration in structuring program access, information, enrollment and qualification.
The discussion on patient affordability in cancer care will be led by Don Sharpe, President, Oncology Business Review, and panelists will include:
- Patricia Goldsmith, Chief Executive Officer, CancerCare
- Lynn Humphrey, Practice Manager, Cancer Center of Santa Barbara
- Debbie Warner, Vice President, Oncology Commercial Strategies, Kantar Health
The webinar is free to attend; registration is available on the event website: http://obroncology.com/webinar/the-ongoing-crisis-and-the-opportunities-for-pharma.php
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.